Background: Comorbid substance use, particularly cannabis among adolescents with mental illness, is a major public health concern in developing countries with limited mental health resources. Better understanding of the association between cannabis use and other polysubstance use and early mental illness will provide for more targeted early interventions.
INTRODUCTION
The relationship between mental illness and substance use is complex and often reciprocal, requiring an integrated response. 1 Patients who present with comorbid substance use are at increased risk for poor clinical and socio-economic outcomes, 2, 3 and present significant challenges in terms of management, especially within resource limited settings. In South Africa, as in many other developing countries, child and adolescent mental health services are scarce, and there are no integrated substance use and psychiatric treatment centres in many areas including in KwaZulu-Natal for mentally ill adolescents with comorbid substance-related disorders.
The prevalence of comorbid substance use disorders in adolescents with mental illness ranges from 20% to 33%, with predominance in males and older adolescents. 4 Substance use is associated with a variety of adolescent psychopathology, particularly the externalizing disorders with varying rates and patterns of substance use. 5 The prevalence of substance use disorders is especially high among patients with early-onset psychosis (EOP) (psychosis onset by age 18) and is often under-detected and untreated. 6 An American study of 75 youth with EOP reported that 45% of the participants had a history of substance abuse or dependence, with alcohol and cannabis being the most commonly abused substances. 6 Cannabis, alcohol and nicotine are the most commonly used substances globally, and there is often polysubstance use in patients with mental illness and particularly psychosis. 7 Cannabis use is also associated with various other non-psychotic mental illnesses in adolescents, including conduct disorders, attention deficit hyperactivity disorder (ADHD), depression and suicidal behaviour. 8 For example, in a review of 236 adolescent psychiatric patients in Israel, the most common diagnoses among cannabis users were ADHD and disruptive behaviour disorder. 8 Studies of cannabis use in adolescents with mental disorders within low-income and middle-income countries, however, are lacking; although recent prevalence studies from South Africa indicate that rates of use in adolescents with FEP are as high in these contexts as in high-income countries. 9, 10 In the Western Cape, Lachman and colleagues found that 44% of men and 10% of women reported cannabis use, 9 whereas in KwaZulu-Natal, a rate of 68% was reported in FEP adolescents. 10 Notably, there are no prevalence studies for substance use in non-psychotic mentally ill adolescents in the South African context.
Studies have investigated the differential susceptibility to cannabis among adults with psychosis compared with the general population and with other mental illness. A study of cannabis use among 80 youth with schizophrenia spectrum disorder reported no significant difference in prevalence of cannabis use or other substance use among psychotic and non-psychotic youth; however, there was an association with earlier age of cannabis initiation and earlier age of onset of psychotic and non-psychotic disorders. 11 Studies have also reported that adult patients with psychosis have a different pattern of substance use with earlier tolerance, loss of control and onset of dependence. 7 This has not been investigated in exclusive adolescent samples.
Understanding the reasons for substance use in adolescents with mental illness is a priority for developing appropriate preventive and treatment interventions. A review in adults with psychosis identified the main reasons for substance use as the intoxicating effects of drugs, social reasons, and relief from dysphoria, psychotic symptoms and/or medication side effects. 2 These authors found considerable variability in reported reasons for use and, among other factors, attributed this variability to heterogeneous study methodologies. Nevertheless, they noted that the most frequently cited reason for use was the alleviation of dysphoric symptoms, and they argue that this supports the self-medication hypothesis. 2 In a more recent review of the self-report literature, it was suggested that psychotic patients use cannabis for its intoxicant effect -as do the general population -and to reduce negative symptoms such as dysphoria. 12 Importantly however, studies on self-reported reasons for cannabis use in EOP and other mental illness in youth are lacking.
Thus, we need to clarify whether substance use varies in its patterns of use and impact in adolescents with psychotic and non-psychotic mental disorders. This has implications for policies and planning of appropriate early interventions in this vulnerable population. The findings of this study are important, as if we address early cannabis use and the associated risk factors in early intervention programmes, we may potentially be able to delay disease onset or outcome.
AIM
With these issues in mind, we set out to compare the specificity of socio-demographic and cannabis use presentations between adolescents with first-episode EOP and a control group of adolescents with a first episode of non-psychotic mental illness. The rationale for comparing psychotic youth with nonpsychotic youth was to establish the specificity of the pattern and influence of these factors on EOP presentation compared with other mental illnesses.
METHOD Study site and population
We conducted a cross-sectional study in a clinical population of adolescents aged 10-18 years with EOP at four public hospital psychiatric units (including the only two adolescent in-patient units) in KwaZulu-Natal, South Africa. A control group matched for age and gender with first-episode nonpsychotic mental illness were recruited from the same services. This method has been used in previous studies to assess specificity of findings in psychosis compared with non-psychotic illness.
11
Consecutive patients meeting inclusion criteria and consented were recruited to the study between March 2013 and May 2015, and all participants and their caregivers provided written informed assent and consent, respectively. The study received ethical approval from the biomedical research ethics committee of the University of KwaZulu-Natal.
Patients with autistic spectrum disorders, intellectual disability, concurrent substance use other than cannabis in the month prior to admission, or significant medical conditions that may have contributed to the mental illness (such as epilepsy or HIV) were excluded in both EOP and control groups. Adolescents with a primary diagnosis of substance-induced mood or psychotic disorder were excluded.
Assessment instruments
All assessments and ratings were conducted by three clinically experienced psychiatrists (SP, SK and KJ) trained in administration of the instruments. Interrater reliability was satisfactory (Cronbach alpha values: r = 0.88; r = 0.91 and r = 0.86). A full clinical assessment comprising a participant and caregiver interview was carried out to allocate a DSM-IV TR clinical diagnosis and obtain socio-demographic information. 13 The World Health Organization (WHO) Alcohol, Smoking and Substance Involvement Screening Test (ASSIST v 3.0) was administered to evaluate substance use.
Definitions
Early onset psychosis (EOP) was defined as onset of psychosis before or at age 18 years.
Substance use was recorded as lifetime history of specific substance use if subject ever used substance.
Cannabis use (CU) was recorded as lifetime history of cannabis use (LCU) if subject ever used cannabis.
Current cannabis use (CCU) was recorded as use in the 3 months prior to first presentation for treatment.
World Health Organization (WHO) ASSIST Specific Substance Involvement Score is a measure of use and problems in the past 3 months prior to presentation for that specific substance as per the ASSIST tool. A score of 0-3 (0-10 for alcohol) for a substance indicates low risk, 4-26 (11-26 for alcohol) indicates moderate risk of harmful or hazardous use of a substance, and scores greater than 27 indicate a high risk of substance dependence.
World Health Organization (WHO) ASSIST Total Substance Involvement Score is the total score for all substances.
Statistical analysis
The data was analysed using the STATA 13.0 (Statacorp. 2013 Stata Statistical Software: Release 13. College Station, TX: Statacorp LP) Lins concordance coefficient and 95% Bland and Altman's limits-of-agreement were used for inter-rater agreement. Means (standard deviations), median (Inter Quintile Range) and range were calculated. The student's t-test was used to compare mean age by gender. Associations between categorical variables were tested using Pearson chisquared (χ 2 ) tests. If an expected cell count was fewer than five observations, then the Fishers exact test was used instead. A P-value of <0.05 was deemed statistically significant.
RESULTS

Socio-demographic and diagnostic characteristics of the sample
Forty-five adolescents with first-episode EOP and 45 controls matched for age and gender with firstepisode mental illness other than psychosis were recruited consecutively in this study. Five EOP patients meeting criteria did not consent, and nine non-psychotic youth refused to consent. There were no differences between groups in terms of gender, age and educational attainment. However, EOP adolescents were predominantly of Black ethnicity (P = <0.001). Adolescents with non-psychotic mental disorders were more likely to live in urban areas (P = <0.001). The socio-demographic characteristics for the adolescents with EOP and the adolescents with other mental illness are presented in Table 1 .
Thirty-eight (84%) adolescents with EOP were diagnosed with schizophrenia spectrum psychotic disorder and 7 (16%) with an affective psychotic disorder.
Diagnoses in the adolescents with non-psychotic disorders were the following: major depressive disorder (n = 25, 55%); ADHD (n = 8, 17%); disruptive behavioural disorders (conduct disorder and oppositional defiant disorder) (n = 6, 13%); conversion disorder (n =2, 4%); bipolar mood disorder (n = 1, 2%); trichotillomania (n =1, 2%); adjustment disorder (n = 1, 2%); and post-traumatic stress disorder (n = 1, 2%).
Cannabis and other substance use patterns
Adolescents with EOP were significantly more likely to have current cannabis use (37.8% vs. 15.6%, P = 0.017) and, although not significant, they were more likely to have a history of lifetime cannabis use (55.56% vs. 35.56%). EOP adolescents were also significantly more likely to have a strong urge or desire to use cannabis, to have tried to cut down on cannabis use and failed, to have a higher ASSIST Specific Substance Involvement Score for cannabis and to be at high risk of cannabis dependence (15.6% vs. 0%). In terms of alcohol use, EOP adolescents were more likely to have related health, social, legal or financial problems, and were less likely to have low-risk use as defined by the ASSIST. Adolescents with EOP also had higher ASSIST Specific Substance Involvement Scores for cocaine, amphetamines, inhalants, sedatives, hallucinogens, opioids and other drugs. The substance use patterns among adolescents with EOP and those with other mental illness are described for each substance in Table 2 .
Socio-demographics of lifetime cannabis users
Cannabis was the most commonly used illicit substance by psychotic and non-psychotic mentally ill adolescents (LCU prevalence 55.6% and 35.6%, respectively). The impact of cannabis use on clinical characteristics of EOP is described in a separate publication.
14 The socio-demographic variables for the adolescents with LCU with and without psychosis are presented in Table 3 . In comparison with controls, EOP adolescents with LCU were more likely to be male and were less likely to live in an urban area. They were less likely to have a first-degree relative with a non-psychotic mental illness although not statistically significant.
Patterns of cannabis use
The patterns of cannabis use in the mentally ill adolescents with and without psychosis are compared in Table 4 . EOP adolescents with LCU were more likely to report their main reason for using cannabis as being for its intoxicant effect, whereas non-psychotic adolescents were more likely to give depression as the main reason for their cannabis use.
DISCUSSION
In this study, we compared socio-demographic and substance use patterns, as well as patterns of cannabis use, in psychotic and non-psychotic mentally ill adolescents at disease onset. A number of our findings have particular public health relevance to the prevention and management of comorbid substance use in adolescents with mental disorders in our context. Firstly, the differences between the EOP and control groups are significant in that these differences likely relate to disparities in access to mental health care for certain youth (see discussion below). Secondly, although LCU prevalence did not differ significantly between groups, use in adolescents with EOP was more frequent, more likely to be of high risk, use preceded onset of symptoms and was for different reasons compared with use in non-psychotic adolescents. This possibly suggests differential susceptibility to the effects of cannabis in psychotic youth compared with other mentally ill adolescents.
Disparities in mental health care access
This study reported some important differences in the socio-demographic profile of EOP and other mentally ill adolescents, which we believe reflect disparities in access to mental health services for the latter group of adolescents. Although the profile of EOP adolescents closely mirrors the general population demographics and is consistent with the literature, 9,15 youth of Black ethnicity, rural residence and low socioeconomic status were under-represented in the control group of non-psychotic adolescents.
Although risk factors related to socioeconomic status and ethnicities are associated with the development of psychosis, 16 and may in part account for some demographic characteristics of the EOP group, one has to consider alternative explanations.
Other explanations include potential socio-cultural influences on accessing mental health care such as parental educational differences, lack of awareness of mental health or facilities, stigma and use of alternative health services such as traditional healers. 17 In addition, the demographic profile of the nonpsychotic sample may be to reflect persistent inequalities in access to mental health care services for adolescents with common and other nonpsychotic mental disorders. Specifically, we contend that within our poorly resourced context, Black youth, youth from rural areas and those from low socio-economic backgrounds have difficulty accessing mental health care unless they are severely ill with psychosis. This is supported by literature reporting the inequalities in mental health care in developing countries with only 15-30% of children and adolescents who require treatment receiving care. 17, 18 This is also consistent with our clinical experience within these services.
Cannabis and other substance use
Alcohol and nicotine were the most commonly used substances by all mentally ill adolescents, whereas cannabis was the most commonly used illicit substance. Lifetime prevalence rates of alcohol, nicotine and cannabis use in this study were high compared with an adolescent in-patient study in Israel, 1 but comparable with previous adult 19, 20 and local adolescent studies. 9 Different definitions of substance use are likely to account for significant variability in substance use prevalence rates in the literature. 2 The prevalence of current cannabis use was higher in adolescents with EOP and more common in males as has been reported previously. 21 Lifetime prevalence rates of other illicit substances were low and did not differ between groups. This may be due to socio-cultural and geographical differences in patterns of use. It may also be due to exclusion of current use in past month of substances other than cannabis as the study aimed to assess cannabis impact on presentation. Psychotic youth were, however, more likely to have problematic use of other substance-related problems, and this is consistent with adult literature. 2, 22 There were significant differences in current use and patterns of cannabis use between adolescents with and without psychosis. Adolescents with EOP had more intense and regular cannabis use (Table 4) , a stronger urge to use cannabis and had greater problematic use (Table 2 ) compared with other mentally ill adolescents. This is consistent with the literature that individuals with psychosis appear to be more vulnerable to the effects of cannabis. 23 Possible reasons for this include genetic susceptibility to cannabis use among individuals with a psychosis vulnerability; increased neurobiological vulnerability to effects of cannabis in adolescent onset psychosis and gender-dependent differences in cannabis vulnerability in adolescents. [24] [25] [26] This is particularly concerning as intensive current cannabis use is significantly associated with a greater negative effect on mental health than past use. In addition, the impact of cannabis on mental health increases with increasing intensity of use. 27 Early and regular cannabis use is also associated with negative effects on psychopathology and psychosocial functioning. 8 Thus, the more frequent and hazardous use of cannabis by adolescents with EOP suggests a poorer outcome for not only the psychotic disorder, 28 but for mental health generally.
The main reasons reported for cannabis use in the current study was markedly different among psychotic and non-psychotic adolescents. The main reason for cannabis use by non-psychotic adolescents was depression, and cannabis use was initiated after symptom onset. This reinforces the need for earlier screening and intervention for adolescent mental health problems to prevent progression to substance use. The reason for cannabis use may have been confounded by the selection of a heterogenous group of psychiatric disorders as controls. In contrast, the finding that EOP adolescents mainly used cannabis for its intoxicant effect and the majority of EOP adolescents initiated cannabis before the onset of positive psychotic symptoms is not in keeping with the self-medication hypothesis. The findings of this study support the suggestion that there are multiple risk factors for substance use in adolescents with EOP, including socio-demographic factors such as gender, living environment, socio-economic status and family history. 2, 12, 29 This multifactorial causation hypothesis of substance use in psychosis is supported in this study as EOP adolescents with LCU were predominantly male, from urban areas and had marginally higher family income than other mentally ill adolescents with LCU. Understanding when, why and who is at risk of cannabis use among mentally ill adolescents is critical to planning appropriate intervention programmes.
In this study, there were no significant associations between cannabis use and family history of mental illness or a family history of psychosis in first-degree relatives; however, EOP adolescents with LCU were less likely to have a first-degree relative with a non-psychotic mental illness. This is not in keeping with the literature that proposes that individuals with a genetic vulnerability to psychosis are more susceptible to cannabis use, 11, 30 but the finding is supported by the Edinburgh High-risk Study that also reported no association between family history of mental illness and cannabis use. 31 However, this requires further study due to the small sample size.
Finally, it is also important to note that only onethird (36.5%) of the adolescents with LCU reported receiving information on substance prevention from their clinic ( Table 4 ). The primary health care clinic serves as the first point of health care contact. The study findings suggest that busy and under-resourced clinics may not be detecting and managing substance use in adolescents. The lack of substance use counselling at clinics in this study reinforces the need for an integrated youth friendly service offering comprehensive mental health and substance use treatment at primary health care level to address the inequalities in mental health care. Although this may be challenging, it could be addressed by training community lay counsellors and primary health care nurses and reviewing our resource allocations to primary health care facilities.
LIMITATIONS OF STUDY
There were several limitations in this study. Although incident EOP is relatively rare, our sample size of 45 adolescents is small and limited the power of the analyses to detect potential associations between variables. In addition, this study relied on selfreporting of substance use and family history of mental illness by the caregiver and patient, which may not always be accurate.
This study is based on a clinical hospital-based sample and this could present an issue of selection bias. However, we recruited from four different mental health care units serving a large part of the province, and in addition, two adolescent in-patient psychiatric units in KwaZulu-Natal that receive all the admissions were included in the study, thus the sample may be considered a fair representation of the clinical population attending state sector mental health services. Importantly, socio-demographic profile and substance use patterns may vary in the private health sector. The clinical sample also limits generalisability, and large epidemiological studies are still needed.
The exclusion of substance-induced psychotic disorder, neurodevelopmental disorders and significant medical illness may be considered a strength of this study as this strategy ensured a homogenous sample of 'functional' EOP. The exclusion of individuals with substance-induced psychosis and substance use other than cannabis in the month prior to presentation may also have under-reported the prevalence of substance use in mentally ill adolescents.
CONCLUSION
The disparity in access to mental health care for Black youth from rural and low socio-economic backgrounds is a major public health concern. Strategies to improve access to care via the integrated primary health care system, education system and traditional healers in the communities need to be urgently addressed. The significantly increased frequency, different motivation for use and more problematic use of cannabis by adolescents with EOP suggest that adolescents with psychosis are more vulnerable to cannabis-related problems than adolescents with other mental illness. Thus, adolescents with EOP and cannabis use are more likely to require management of both the psychosis and substance use and hence a need for integrated mental health care and substance use treatment centres to address the current deficits in care.
